Allergic rhinitis, commonly known as hay fever, is a condition characterized by sneezing, itchy, runny or blocked nose as a result of an allergic response to certain substances in the air like dust, pollen, animal dander, or molds. Symptoms appear when the person is exposed to an allergen they are sensitive to.Treatment options for allergic rhinitis include allergen immunotherapy, antihistamines, intranasal corticosteroids, decongestants & leukotriene receptor antagonists. Rising pollution levels and changing climate conditions are contributing significantly to increased prevalence of allergic diseases globally.
The global allergic rhinitis treatment market is estimated to be valued at US$ 20.94 Bn in 2024 and is expected to exhibit a CAGR of 9.0% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in The Allergic Rhinitis Treatment are Abbott, Emerson electricco., Honeywell international, Inc., Kawasakiheavy Industries, Ltd., Mitsubishi electric corporation, Omron corporation, Rockwell automation,Inc., And Schneiderelectric. Growing pollution levels and lack of air quality standards in developing nations is driving greater demand for allergic rhinitis treatment solutions. Companies are investing heavily in R&D to develop more effective drugs to treat symptoms and bring relief to millions of patients globally. The global allergic rhinitis treatment market is expected witness high growth in Asia Pacific region owing to improving access to healthcare and large patient pool.
Market Drivers
Rising levels of air pollution across major cities worldwide due to rapid industrialization and urbanization is a key factor augmenting the prevalence of allergic rhinitis. Conditions such as smog, emissions from vehicles and factories increase exposure to outdoor allergens and pollutants that trigger allergic reactions. Climate change is also exacerbating the production and dispersal of airborne allergens like pollen which increases severity and duration of the allergy season. Growing health awareness regarding allergies and availability of various treatment options is encouraging patients to seek medical help rather than ignore symptoms. This is expected to support market growth over the forecast period.
Current Geopolitical Situation and Its Impact on Allergic Rhinitis Treatment Market Growth
The ongoing geopolitical tensions and conflicts across various regions have significantly impacted the growth of the allergic rhinitis treatment market in recent years. The supply chain disruptions caused by the Russia-Ukraine war have interrupted the steady flow of raw materials needed for manufacturing allergy drugs. Several drug makers have reported production delays and shortages of key ingredients after supply lines from Eastern Europe were halted. The rising economic sanctions and restrictions have made it difficult to import APIs and intermediates from sanctioned countries. This has constrained the manufacturing output of antihistamine and corticosteroid nasal sprays used to treat allergic rhinitis.
Furthermore, the Covid19 pandemic upended global trade and travel over the past two years, exacerbating the geopolitical risks. Countries have tightened border controls to curb disease transmission, creating additional hurdles for cross-border product exchanges and clinical trials. The rising costs of logistics and scarcity of shipping containers inflated the overall costs for drug makers. While most companies have activated alternative sourcing strategies, it will take time to establish robust and geographically diverse supply networks post pandemic. Overall, geopolitical tensions have dampened market fortunes in the short-term by disrupting operations and inflating costs. Drug makers will need to diversify their sourcing bases and enhance inventory management to navigate future supply chain shocks.
Geographical Regions of Concentrated Value in Allergic Rhinitis Treatment Market
The allergic rhinitis treatment market in terms of value is highly concentrated in developed regions of North America and Europe. According to market estimates, over 60% of the global market revenues are generated from the United States and major European Union countries together. This is attributed to rising healthcare expenditures per capita and high adoption of prescription drugs in these regions. The United States represents the single largest market, valued at over US$ 7 billion currently due to large disease prevalence and strong reimbursement structure favoring expensive biologic drugs. Other matured markets include Germany, France, United Kingdom, Italy, and Spain, which also contribute significantly to the global market pool. However, growth rates in these areas have slowed in recent years due to market saturation.
Fastest Growing Region in Allergic Rhinitis Treatment Market
The Asia Pacific region, particularly China and India, is poised to be the fastest growing market for allergic rhinitis treatment during the forecast period from 2024-2031. Key factors driving robust expansion include rising environmental pollution levels leading to increased allergy cases, growing health awareness, rapidly developing healthcare infrastructure, and rising disposable incomes in emerging Asian economies. Furthermore, several large pharmaceutical companies have established manufacturing facilities and R&D centers in Asia to benefit from low production costs and a sizable patient pool. It is expected that the Asia Pacific region will see a CAGR of over 12% during the forecast period, outpacing global market growth. Increased accessibility of drugs, rising healthcare expenditures, and favorable regulatory environment are other factors that will support the Asia Pacific region to emerge as the new hotspot for allergic rhinitis treatment market in the coming years.
Get More Insights On Allergic Rhinitis Treatment Market
